Childhood Atypical Teratoid/Rhabdoid Tumor Treatment


Purpose of This PDQ Summary


General Information


Background Information About Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor


Cellular Classification and Tumor Biology of Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor


Stage Information


Treatment for Newly Diagnosed Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor


Treatment for Recurrent Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor


Get More Information From NCI


		Changes to This Summary (08/04/2009)


More Information

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp online chat

	NCI Highlights


	Office of Biorepositories and Biospecimen Research The Nation's Investment in Cancer Research FY 2010 Report to Nation Finds Declines in Cancer Incidence, Death Rates

Changes to This Summary (08/04/2009)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Treatment for Newly Diagnosed Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor

Added Gardner et al. as reference 4 and level of evidence 3iiiDi.

Added text on a study of intensive multimodality treatment for children with newly diagnosed central nervous system atypical teratoid/rhabdoid tumor (cited Chi et al. as reference 8).

< Previous Section | Next Section >